PEDIATRICS Vol. 89 No. 1 January 1992, pp. 107-113
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ostrea, E. M.
Right arrow Articles by Stevens, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ostrea, E. M., Jr
Right arrow Articles by Stevens, M.

Drug Screening of Newborns by Meconium Analysis: A Large-Scale, Prospective, Epidemiologic Study

Enrique M. Ostrea Jr MD1, Mark Brady 1, Sybil Gause 1, Anna Lisa Raymundo 1, and Maria Stevens 1

1 From the Department of Pediatrics, Hutzel Hospital, Wayne State University, Detroit, MI.

A large-scale, prospective drug screening of newborns by meconium analysis was done to determine more accurately the prevalence and epidemiologic characteristics of drug use in a high-risk urban, obstetric population. Every other neonate delivered in a perinatal center from November 1988 to September 1989 was prospectively enrolled and their meconium was analyzed by radioimmunoassay for the metabolites of three commonly abused drugs—cocaine, morphine (opiates), and cannabinoid. In 3010 subjects studied, 44% were positive for cocaine, morphine, or cannabinoid; 31% were positive for cocaine, 21% for morphine, and 12% for cannabinoid. In contrast, only 335 (11%) mothers admitted to illicit drug use: 52% of their newborns had a positive urine drug screen and 88% had a positive meconium drug screen. Prevalence of drug use among the pregnant women varied per month. A profile of the pregnant addict in the population studied was noted (P < .001): service patient, single, multigravid (>3), and little or no prenatal care. The major problems associated with drug use during pregnancy were principally noted in the group that was exposed to cocaine and opiates and in the group where the mothers admitted to the use of illicit drugs. On the other hand, a large number of neonates who have been exposed to drugs in utero, particularly those whose mothers denied the use of drugs, appear normal at birth and may not be recognized. Improved detection of these newborns at risk can be achieved with a high index of suspicion and meconium drug analysis.

Key Words: meconium • drug abuse • neonate • opiates • cocaine • cannabinoid

Submitted on February 4, 1991
Accepted on June 24, 1991




This article has been cited by other articles:


Home page
 PediatricsHome page
M. J. Rivkin, P. E. Davis, J. L. Lemaster, H. J. Cabral, S. K. Warfield, R. V. Mulkern, C. D. Robson, R. Rose-Jacobs, and D. A. Frank
Volumetric MRI Study of Brain in Children With Intrauterine Exposure to Cocaine, Alcohol, Tobacco, and Marijuana
Pediatrics, April 1, 2008; 121(4): 741 - 750.
[Abstract] [Full Text] [PDF]

Home page
 Probation JournalHome page
R. Bloor, D. Okolo, and D. Watts
Pregnancy and coerced drug treatment services: A cause for concern?
Probation Journal, September 1, 2007; 54(3): 263 - 270.
[Abstract] [PDF]

Home page
 Arch. Dis. Child. Fetal Neonatal Ed.Home page
M. Anderson and I. Choonara
Drug misuse during pregnancy and fetal toxicity
Arch. Dis. Child. Fetal Neonatal Ed., September 1, 2007; 92(5): F332 - F333.
[Full Text] [PDF]

Home page
 Arch. Dis. Child. Fetal Neonatal Ed.Home page
S Williamson, L Jackson, C Skeoch, G Azzim, and R Anderson
Determination of the prevalence of drug misuse by meconium analysis.
Arch. Dis. Child. Fetal Neonatal Ed., July 1, 2006; 91(4): F291 - F292.
[Abstract] [Full Text] [PDF]

Home page
 J Pediatr PsycholHome page
M. Beeghly, B. Martin, R. Rose-Jacobs, H. Cabral, T. Heeren, M. Augustyn, D. Bellinger, and D. A. Frank
Prenatal Cocaine Exposure and Children's Language Functioning at 6 and 9.5 Years: Moderating Effects of Child Age, Birthweight, and Gender
J. Pediatr. Psychol., January 1, 2006; 31(1): 98 - 115.
[Abstract] [Full Text] [PDF]

Home page
 The Journal of the Royal Society for the Promotion of HealthHome page
Z. Kassim and A. Greenough
Effects of substance abuse during pregnancy
The Journal of the Royal Society for the Promotion of Health, September 1, 2005; 125(5): 212 - 214.
[PDF]

Home page
 Arch. Dis. Child. Fetal Neonatal Ed.Home page
L Jackson, A Ting, S Mckay, P Galea, and C Skeoch
A randomised controlled trial of morphine versus phenobarbitone for neonatal abstinence syndrome
Arch. Dis. Child. Fetal Neonatal Ed., July 1, 2004; 89(4): F300 - F304.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
M. A. Tan-Laxa, C. Sison-Switala, W. Rintelman, and E. M. Ostrea Jr
Abnormal Auditory Brainstem Response Among Infants With Prenatal Cocaine Exposure
Pediatrics, February 1, 2004; 113(2): 357 - 360.
[Abstract] [Full Text] [PDF]

Home page
 CLIN PEDIATRHome page
A. M. Butz, M. B. Pulsifer, M. Leppert, S. Rimrodt, and H. Belcher
Comparison of Intelligence, School Readiness Skills, and Attention in In-Utero Drug-Exposed and Nonexposed Preschool Children
Clinical Pediatrics, October 1, 2003; 42(8): 727 - 739.
[Abstract] [PDF]

Home page
 Am J EpidemiolHome page
C. Derauf, A. R. Katz, and D. Easa
Agreement between Maternal Self-reported Ethanol Intake and Tobacco Use During Pregnancy and Meconium Assays for Fatty Acid Ethyl Esters and Cotinine
Am. J. Epidemiol., October 1, 2003; 158(7): 705 - 709.
[Abstract] [Full Text] [PDF]

Home page
 NeoReviewsHome page
D. Chan, J. Klein, and G. Koren
New Methods for Neonatal Drug Screening
NeoReviews, September 1, 2003; 4(9): e236 - 244.
[Full Text] [PDF]

Home page
 Br. J. PsychiatryHome page
K. JOHNSON, C. GERADA, and A. GREENOUGH
Substance misuse during pregnancy
The British Journal of Psychiatry, September 1, 2003; 183(3): 187 - 189.
[Full Text] [PDF]

Home page
 PediatricsHome page
D. A. Frank, R. R. Jacobs, M. Beeghly, M. Augustyn, D. Bellinger, H. Cabral, and T. Heeren
Level of Prenatal Cocaine Exposure and Scores on the Bayley Scales of Infant Development: Modifying Effects of Caregiver, Early Intervention, and Birth Weight
Pediatrics, December 1, 2002; 110(6): 1143 - 1152.
[Abstract] [Full Text] [PDF]

Home page
 Arch Pediatr Adolesc MedHome page
A. M. Butz, M. Pulsifer, N. Marano, H. Belcher, M. K. Lears, and R. Royall
Effectiveness of a Home Intervention for Perceived Child Behavioral Problems and Parenting Stress in Children With In Utero Drug Exposure
Arch Pediatr Adolesc Med, September 1, 2001; 155(9): 1029 - 1037.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
D. A. Frank, M. Augustyn, W. G. Knight, T. Pell, and B. Zuckerman
Growth, Development, and Behavior in Early Childhood Following Prenatal Cocaine Exposure: A Systematic Review
JAMA, March 28, 2001; 285(12): 1613 - 1625.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
M. A. Alano, E. Ngougmna, E. M. Ostrea Jr, and G. G. Konduri
Analysis of Nonsteroidal Antiinflammatory Drugs in Meconium and Its Relation to Persistent Pulmonary Hypertension of the Newborn
Pediatrics, March 1, 2001; 107(3): 519 - 523.
[Abstract] [Full Text]

Home page
 PediatricsHome page
B. M. Lester, M. ElSohly, L. L. Wright, V. L. Smeriglio, J. Verter, C. R. Bauer, S. Shankaran, H. S. Bada, H. C. Walls, M. A. Huestis, et al.
The Maternal Lifestyle Study: Drug Use by Meconium Toxicology and Maternal Self-Report
Pediatrics, February 1, 2001; 107(2): 309 - 317.
[Abstract] [Full Text]

Home page
 PediatricsHome page
D. A. Dempsey, B. L. Hajnal, J. C. Partridge, S. N. Jacobson, W. Good, R. T. Jones, and D. M. Ferriero
Tone Abnormalities Are Associated With Maternal Cigarette Smoking During Pregnancy in In Utero Cocaine-Exposed Infants
Pediatrics, July 1, 2000; 106(1): 79 - 85.
[Abstract] [Full Text]

Home page
 Child MaltreatHome page
S. J. Ondersma, S. M. Simpson, E. V. Brestan, and M. Ward
Prenatal Drug Exposure and Social Policy: The Search for an Appropriate Response
Child Maltreat, May 1, 2000; 5(2): 93 - 108.
[Abstract] [PDF]

Home page
 PediatricsHome page
S. M. Potter, P. R. Zelazo, D. M. Stack, and A. N. Papageorgiou
Adverse Effects of Fetal Cocaine Exposure on Neonatal Auditory Information Processing
Pediatrics, March 1, 2000; 105(3): 40e - 40.
[Abstract] [Full Text]

Home page
 PediatricsHome page
D. A. Frank, K. M. McCarten, C. D. Robson, M. Mirochnick, H. Cabral, H. Park, and B. Zuckerman
Level of In Utero Cocaine Exposure and Neonatal Ultrasound Findings
Pediatrics, November 1, 1999; 104(5): 1101 - 1105.
[Abstract] [Full Text]

Home page
 PediatricsHome page
R. H. Schwartz
Adolescent Heroin Use: A Review
Pediatrics, December 1, 1998; 102(6): 1461 - 1466.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
J. M. Leventhal, B. W. C. Forsyth, K. Qi, M. L. Johnson, D. Schroeder, and N. Votto
Maltreatment of Children Born to Women Who Used Cocaine During Pregnancy: A Population-based Study
Pediatrics, August 1, 1997; 100(2): e7 - e7.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
E. M. Ostrea Jr, A. R. Ostrea, and P. M. Simpson
Mortality Within the First 2 Years in Infants Exposed to Cocaine, Opiate, or Cannabinoid During Gestation
Pediatrics, July 1, 1997; 100(1): 79 - 83.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurophysiol.Home page
S. C. Baraban and P. A. Schwartzkroin
Effects of Prenatal Cocaine Exposure on the Developing Hippocampus: Intrinsic and Synaptic Physiology
J Neurophysiol, January 1, 1997; 77(1): 126 - 136.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
T. C. Kwong and R. M. Ryan
Detection of intrauterine illicit drug exposure by newborn drug testing
Clin. Chem., January 1, 1997; 43(1): 235 - 242.
[Abstract] [Full Text] [PDF]

Home page
 CLIN PEDIATRHome page
R. Beltran, T. Bell, S. Fisher, and S. Ros
Utility of Laboratory Screening in Cocaine-Exposed Infants
Clinical Pediatrics, November 1, 1994; 33(11): 683 - 685.
[PDF]

Home page
 CLIN PEDIATRHome page
M. L. Angelilli, H. Fischer, V. Delaney-Black, M. Rubinstein, J. W. Ager, and R. J. Sokol
History of In Utero Cocaine Exposure in Language-Delayed Children
Clinical Pediatrics, September 1, 1994; 33(9): 514 - 516.
[Abstract] [PDF]

Home page
 CLIN PEDIATRHome page
P. Nair, S. Rothblum, and R. Hebel
Neonatal Outcome in Infants With Evidence of Fetal Exposure to Opiates, Cocaine, and Cannabinoids
Clinical Pediatrics, May 1, 1994; 33(5): 280 - 285.
[Abstract] [PDF]

Home page
 NEJMHome page
W. A. Vega, B. Kolody, J. Hwang, and A. Noble
Prevalence and Magnitude of Perinatal Substance Exposures in California
N. Engl. J. Med., September 16, 1993; 329(12): 850 - 854.
[Abstract] [Full Text]